폐쇄형 약물전달 기기 시장 : 유형별, 구성요소별, 최종 사용자별 - 세계 기회 분석 및 산업 예측(2024-2033년)

Closed System Drug Transfer Device Market By Type , By Component By End user : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,228,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,432,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

폐쇄형 약물전달 기기(CSTD) 시장

폐쇄형 약물전달 기기(CSTD) 시장은 2023년 8억 달러로 평가되며 2024년부터 2033년까지 연평균 15.7% 성장하여 2033년에는 36억 달러에 달할 것으로 예상됩니다.

폐쇄형 약물전달 기기(CSTD)는 시스템의 내부 환경과 외부 환경과의 접촉을 방지하는 의료기기로, 주변에서 의료기기 및 시스템에 오염 물질이 유입되는 것을 방지하고 시스템에서 외부 환경으로 위험한 화학 물질과 증기를 피하는 것을 금지합니다. 이러한 장치는 세포 독성 및 기형 유발 가능성이 높은 약물로부터 환자와 병원 내에서 일하는 의료진의 안전을 보호하는 데 매우 중요합니다.

암 및 기타 만성 질환의 유병률이 증가함에 따라 대부분의 의료 환경에서 CSTD의 도입이 필수적인 요소로 자리 잡으며 시장 성장을 견인하고 있습니다. 또한, 산업안전보건국과 미국 약전 등 여러 규제 기관의 규제 시행으로 CSTD에 대한 수요가 증가하고 있으며, CSTD와 자동화 및 로봇 공학의 통합은 약국 및 조제 시설에서 위험한 화학 물질의 효율적인 취급 및 사용을 보장하기 위해 큰 주목을 받고 있는 추세입니다. 추세입니다.

그러나 다양한 크기의 주사기, 약물 바이알, 주입 시스템과 CSTD의 호환성과 관련된 기술적 장애물은 오작동 위험을 초래하고 폐쇄형 약물전달 기기(CSTD) 시장 개척을 방해하고 있습니다. 또한 CSTD를 사용하려면 높은 숙련도와 전문 교육이 필요하며, 일반적으로 자원 집약적이고 시간이 많이 소요됩니다. 이는 시장 성장의 걸림돌로 작용하고 있습니다. 반면, 암 환자의 급격한 증가는 시장에 유리한 성장 기회를 제공할 것으로 예상됩니다. 암 환자 수는 2040년까지 연간 3,000만 명씩 증가할 것으로 예상되며, 이에 따라 병원에서 CSTD를 사용해야 할 필요성이 대두되고 있습니다.

부문별 리뷰

폐쇄형 약물전달 기기(CSTD) 시장은 유형, 구성 요소, 최종 사용자, 지역으로 분류됩니다. 유형별로는 멤브레인 투 멤브레인(Membrane to Membrane)과 니들리스(Needleless)로 나뉩니다. 구성 요소별로는 배리어 유형 CSTD와 공기 정화 CSTD로 나뉩니다. 최종사용자 기준으로는 병원 및 클리닉, 종양센터, 기타로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, LAMEA로 분석됩니다.

주요 조사 결과

유형별로는 멤브레인 투 멤브레인(Membrane to Membrane) 부문이 폐쇄형 약물전달 기기(CSTD) 시장을 독점하고 있습니다.

최종 사용자별로는 병원 및 클리닉용이 높은 점유율을 차지하고 있습니다.

지역별로는 북미가 폐쇄형 약물전달 기기(CSTD) 시장의 주요 수익원입니다.

이 보고서는 사용자 정의가 가능합니다.

• 규제 가이드라인
• 고객의 관심사에 따른 추가 기업 프로파일
• 평균 판매가격 분석/가격대 분석
• 과거 시장 데이터
• 상환 시나리오

목차

제1장 서론

제2장 주요 요약

제3장 시장 구도

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter의 Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 폐쇄형 약물전달 기기(CSTD) 시장 : 유형별

• 시장 개요
• Membrane To Membrane
• Needleless

제5장 폐쇄형 약물전달 기기(CSTD) 시장 : 컴포넌트별

• 시장 개요
• Barrier Type CSTDs
• Air Cleaning CSTDs

제6장 폐쇄형 약물전달 기기(CSTD) 시장 : 최종사용자별

• 시장 개요
• 병원 및 진료소
• 종양 센터
• 기타

제7장 폐쇄형 약물전달 기기(CSTD) 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국 폐쇄형 약물전달 기기(CSTD) 시장
  • 캐나다 폐쇄형 약물전달 기기(CSTD) 시장
  • 멕시코 폐쇄형 약물전달 기기(CSTD) 시장
• 유럽
  • 주요 시장 동향과 기회
  • 프랑스 폐쇄형 약물전달 기기(CSTD) 시장
  • 독일 폐쇄형 약물전달 기기(CSTD) 시장
  • 이탈리아 폐쇄형 약물전달 기기(CSTD) 시장
  • 스페인 폐쇄형 약물전달 기기(CSTD) 시장
  • 영국 폐쇄형 약물전달 기기(CSTD) 시장
  • 기타 유럽 폐쇄형 약물전달 기기(CSTD) 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 중국 폐쇄형 약물전달 기기(CSTD) 시장
  • 일본 폐쇄형 약물전달 기기(CSTD) 시장
  • 인도 폐쇄형 약물전달 기기(CSTD) 시장
  • 한국 폐쇄형 약물전달 기기(CSTD) 시장
  • 호주 폐쇄형 약물 이송 장비(CSTD) 시장
  • 기타 아시아태평양 폐쇄형 약물 이송 장비(CSTD) 시장
• 라틴아메리카/중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질 폐쇄형 약물전달 기기(CSTD) 시장
  • 남아프리카공화국 폐쇄형 약물전달 기기(CSTD) 시장
  • 사우디아라비아 폐쇄형 약물전달 기기(CSTD) 시장
  • 기타 라틴아메리카/중동 및 아프리카 폐쇄형 약물전달 기기(CSTD) 시장

제8장 경쟁 구도

• 서론
• 주요 성공 전략
• 주요 10개 기업의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제9장 기업 개요

• B. Braun Holding GmbH And Co. KG
• Baxter International
• Becton, Dickinson And Company
• Caragen Ltd.
• Corvida Medical
• Equashield
• FIMI Opportunity Funds(Simplivia Healthcare)
• ICU Medical
• JCB Co Ltd.
• Yukon Medical

LSH

영문 목차

영문목차

Closed System Drug Transfer Device (CSTD) Market

The closed system drug transfer device (CSTD) market was valued at $0.8 billion in 2023 and is projected to reach $3.6 billion by 2033, growing at a CAGR of 15.7% from 2024 to 2033.

A closed system drug transfer device (CSTD) is a medical equipment which prevents contact between the inner environment of a system and the outer surroundings. CSTD forbids the entry of contaminants from the surroundings into medical equipment or system and prohibits the evasion of hazardous chemicals or vapors from the system to the external environment. These devices are critical for the safety of both patients and the medical professionals working in a hospital setting from probable cytotoxic or teratogenic agents.

With increasing prevalence of cancer and other chronic diseases, the adoption of CSTD is becoming essential in most healthcare settings, hence driving the growth of the market. In addition, implementation of regulatory mandates by several governing bodies such as Occupational Safety and Health Administration and the United States Pharmacopeia is boosting the demand for CSTDs. The integration of CSTDs with automation & robotics is a trend gaining significant prominence in pharmacies and drug preparation facilities to ensure efficient handling and usage of hazardous chemicals.

However, technical hurdles associated with the compatibility of CSTDs with diverse sizes of syringes, drug vials, and infusion systems pose the risk of malfunctions and hamper the development of the closed system drug transfer device (CSTD) market. Moreover, the usage of CSTDs requires high proficiency and specialized training, which is usually resource-intensive and laborious. This hampers the market growth. Contrarily, the exponentially rising cases of cancer are anticipated to present lucrative growth opportunities for the market. The number of cancer cases are expected to increase at the rate of 30 million new cases per year by 2040, thereby necessitating the use of CSTDs in hospitals.

Segment Review

The closed system drug transfer device (CSTD) market is segmented into type, component, end user, and region. On the basis of type, the market is bifurcated into membrane to membrane and needleless. Depending on component, it is divided into barrier type CSTDs and air cleaning CSTDs. As per end user, it is categorized into hospitals & clinics, oncology centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the membrane to membrane segment dominates the closed system drug transfer device (CSTD) market.

As per end user, the hospitals & clinics segment holds a high share of the market.

Region wise, North America is the major revenue generator of the closed system drug transfer device (CSTD) market.

Competition Analysis

The key players operating in the global closed system drug transfer device (CSTD) market include B. Braun Holding GmbH & Co. KG, Baxter International, Becton, Dickinson and Company, Caragen Ltd., Corvida Medical, Equashield, FIMI Opportunity Funds (Simplivia Healthcare), ICU Medical, JCB Co Ltd., and Yukon Medical. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Average Selling Price Analysis / Price Point Analysis
• Historic market data
• Reimbursement Scenario

Key Market Segments

By Component

• Barrier type CSTDs
• Air cleaning CSTDs

By End User

• Hospitals and Clinics
• Oncology Centers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

By Type

• Membrane to membrane
• Needleless

Key Market Players:

• B. Braun Holding GmbH & Co. KG
• Baxter International
• Becton, Dickinson and Company
• Caragen Ltd.
• Corvida Medical
• Equashield
• FIMI Opportunity Funds (Simplivia Healthcare)
• ICU Medical
• JCB Co Ltd.
• Yukon Medical

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.4. Market Dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Type
• 4.2. Membrane To Membrane
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Needleless
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COMPONENT

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Component
• 5.2. Barrier Type CSTDs
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Air Cleaning CSTDs
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By End User
• 6.2. Hospitals And Clinics
  • 6.2.1. Key Market Trends, Growth Factors and Opportunities
  • 6.2.2. Market Size and Forecast, By Region
  • 6.2.3. Market Share Analysis, By Country
• 6.3. Oncology Centers
  • 6.3.1. Key Market Trends, Growth Factors and Opportunities
  • 6.3.2. Market Size and Forecast, By Region
  • 6.3.3. Market Share Analysis, By Country
• 6.4. Others
  • 6.4.1. Key Market Trends, Growth Factors and Opportunities
  • 6.4.2. Market Size and Forecast, By Region
  • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION

• 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Region
• 7.2. North America
  • 7.2.1. Key Market Trends and Opportunities
  • 7.2.2. Market Size and Forecast, By Type
  • 7.2.3. Market Size and Forecast, By Component
  • 7.2.4. Market Size and Forecast, By End User
  • 7.2.5. Market Size and Forecast, By Country
  • 7.2.6. U.S. Closed System Drug Transfer Device (CSTD) Market
    • 7.2.6.1. Market Size and Forecast, By Type
    • 7.2.6.2. Market Size and Forecast, By Component
    • 7.2.6.3. Market Size and Forecast, By End User
  • 7.2.7. Canada Closed System Drug Transfer Device (CSTD) Market
    • 7.2.7.1. Market Size and Forecast, By Type
    • 7.2.7.2. Market Size and Forecast, By Component
    • 7.2.7.3. Market Size and Forecast, By End User
  • 7.2.8. Mexico Closed System Drug Transfer Device (CSTD) Market
    • 7.2.8.1. Market Size and Forecast, By Type
    • 7.2.8.2. Market Size and Forecast, By Component
    • 7.2.8.3. Market Size and Forecast, By End User
• 7.3. Europe
  • 7.3.1. Key Market Trends and Opportunities
  • 7.3.2. Market Size and Forecast, By Type
  • 7.3.3. Market Size and Forecast, By Component
  • 7.3.4. Market Size and Forecast, By End User
  • 7.3.5. Market Size and Forecast, By Country
  • 7.3.6. France Closed System Drug Transfer Device (CSTD) Market
    • 7.3.6.1. Market Size and Forecast, By Type
    • 7.3.6.2. Market Size and Forecast, By Component
    • 7.3.6.3. Market Size and Forecast, By End User
  • 7.3.7. Germany Closed System Drug Transfer Device (CSTD) Market
    • 7.3.7.1. Market Size and Forecast, By Type
    • 7.3.7.2. Market Size and Forecast, By Component
    • 7.3.7.3. Market Size and Forecast, By End User
  • 7.3.8. Italy Closed System Drug Transfer Device (CSTD) Market
    • 7.3.8.1. Market Size and Forecast, By Type
    • 7.3.8.2. Market Size and Forecast, By Component
    • 7.3.8.3. Market Size and Forecast, By End User
  • 7.3.9. Spain Closed System Drug Transfer Device (CSTD) Market
    • 7.3.9.1. Market Size and Forecast, By Type
    • 7.3.9.2. Market Size and Forecast, By Component
    • 7.3.9.3. Market Size and Forecast, By End User
  • 7.3.10. UK Closed System Drug Transfer Device (CSTD) Market
    • 7.3.10.1. Market Size and Forecast, By Type
    • 7.3.10.2. Market Size and Forecast, By Component
    • 7.3.10.3. Market Size and Forecast, By End User
  • 7.3.11. Rest of Europe Closed System Drug Transfer Device (CSTD) Market
    • 7.3.11.1. Market Size and Forecast, By Type
    • 7.3.11.2. Market Size and Forecast, By Component
    • 7.3.11.3. Market Size and Forecast, By End User
• 7.4. Asia-Pacific
  • 7.4.1. Key Market Trends and Opportunities
  • 7.4.2. Market Size and Forecast, By Type
  • 7.4.3. Market Size and Forecast, By Component
  • 7.4.4. Market Size and Forecast, By End User
  • 7.4.5. Market Size and Forecast, By Country
  • 7.4.6. China Closed System Drug Transfer Device (CSTD) Market
    • 7.4.6.1. Market Size and Forecast, By Type
    • 7.4.6.2. Market Size and Forecast, By Component
    • 7.4.6.3. Market Size and Forecast, By End User
  • 7.4.7. Japan Closed System Drug Transfer Device (CSTD) Market
    • 7.4.7.1. Market Size and Forecast, By Type
    • 7.4.7.2. Market Size and Forecast, By Component
    • 7.4.7.3. Market Size and Forecast, By End User
  • 7.4.8. India Closed System Drug Transfer Device (CSTD) Market
    • 7.4.8.1. Market Size and Forecast, By Type
    • 7.4.8.2. Market Size and Forecast, By Component
    • 7.4.8.3. Market Size and Forecast, By End User
  • 7.4.9. South Korea Closed System Drug Transfer Device (CSTD) Market
    • 7.4.9.1. Market Size and Forecast, By Type
    • 7.4.9.2. Market Size and Forecast, By Component
    • 7.4.9.3. Market Size and Forecast, By End User
  • 7.4.10. Australia Closed System Drug Transfer Device (CSTD) Market
    • 7.4.10.1. Market Size and Forecast, By Type
    • 7.4.10.2. Market Size and Forecast, By Component
    • 7.4.10.3. Market Size and Forecast, By End User
  • 7.4.11. Rest of Asia-Pacific Closed System Drug Transfer Device (CSTD) Market
    • 7.4.11.1. Market Size and Forecast, By Type
    • 7.4.11.2. Market Size and Forecast, By Component
    • 7.4.11.3. Market Size and Forecast, By End User
• 7.5. LAMEA
  • 7.5.1. Key Market Trends and Opportunities
  • 7.5.2. Market Size and Forecast, By Type
  • 7.5.3. Market Size and Forecast, By Component
  • 7.5.4. Market Size and Forecast, By End User
  • 7.5.5. Market Size and Forecast, By Country
  • 7.5.6. Brazil Closed System Drug Transfer Device (CSTD) Market
    • 7.5.6.1. Market Size and Forecast, By Type
    • 7.5.6.2. Market Size and Forecast, By Component
    • 7.5.6.3. Market Size and Forecast, By End User
  • 7.5.7. South Africa Closed System Drug Transfer Device (CSTD) Market
    • 7.5.7.1. Market Size and Forecast, By Type
    • 7.5.7.2. Market Size and Forecast, By Component
    • 7.5.7.3. Market Size and Forecast, By End User
  • 7.5.8. Saudi Arabia Closed System Drug Transfer Device (CSTD) Market
    • 7.5.8.1. Market Size and Forecast, By Type
    • 7.5.8.2. Market Size and Forecast, By Component
    • 7.5.8.3. Market Size and Forecast, By End User
  • 7.5.9. Rest of LAMEA Closed System Drug Transfer Device (CSTD) Market
    • 7.5.9.1. Market Size and Forecast, By Type
    • 7.5.9.2. Market Size and Forecast, By Component
    • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top Winning Strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. B. Braun Holding GmbH And Co. KG
  • 9.1.1. Company Overview
  • 9.1.2. Key Executives
  • 9.1.3. Company Snapshot
  • 9.1.4. Operating Business Segments
  • 9.1.5. Product Portfolio
  • 9.1.6. Business Performance
  • 9.1.7. Key Strategic Moves and Developments
• 9.2. Baxter International
  • 9.2.1. Company Overview
  • 9.2.2. Key Executives
  • 9.2.3. Company Snapshot
  • 9.2.4. Operating Business Segments
  • 9.2.5. Product Portfolio
  • 9.2.6. Business Performance
  • 9.2.7. Key Strategic Moves and Developments
• 9.3. Becton, Dickinson And Company
  • 9.3.1. Company Overview
  • 9.3.2. Key Executives
  • 9.3.3. Company Snapshot
  • 9.3.4. Operating Business Segments
  • 9.3.5. Product Portfolio
  • 9.3.6. Business Performance
  • 9.3.7. Key Strategic Moves and Developments
• 9.4. Caragen Ltd.
  • 9.4.1. Company Overview
  • 9.4.2. Key Executives
  • 9.4.3. Company Snapshot
  • 9.4.4. Operating Business Segments
  • 9.4.5. Product Portfolio
  • 9.4.6. Business Performance
  • 9.4.7. Key Strategic Moves and Developments
• 9.5. Corvida Medical
  • 9.5.1. Company Overview
  • 9.5.2. Key Executives
  • 9.5.3. Company Snapshot
  • 9.5.4. Operating Business Segments
  • 9.5.5. Product Portfolio
  • 9.5.6. Business Performance
  • 9.5.7. Key Strategic Moves and Developments
• 9.6. Equashield
  • 9.6.1. Company Overview
  • 9.6.2. Key Executives
  • 9.6.3. Company Snapshot
  • 9.6.4. Operating Business Segments
  • 9.6.5. Product Portfolio
  • 9.6.6. Business Performance
  • 9.6.7. Key Strategic Moves and Developments
• 9.7. FIMI Opportunity Funds (Simplivia Healthcare)
  • 9.7.1. Company Overview
  • 9.7.2. Key Executives
  • 9.7.3. Company Snapshot
  • 9.7.4. Operating Business Segments
  • 9.7.5. Product Portfolio
  • 9.7.6. Business Performance
  • 9.7.7. Key Strategic Moves and Developments
• 9.8. ICU Medical
  • 9.8.1. Company Overview
  • 9.8.2. Key Executives
  • 9.8.3. Company Snapshot
  • 9.8.4. Operating Business Segments
  • 9.8.5. Product Portfolio
  • 9.8.6. Business Performance
  • 9.8.7. Key Strategic Moves and Developments
• 9.9. JCB Co Ltd.
  • 9.9.1. Company Overview
  • 9.9.2. Key Executives
  • 9.9.3. Company Snapshot
  • 9.9.4. Operating Business Segments
  • 9.9.5. Product Portfolio
  • 9.9.6. Business Performance
  • 9.9.7. Key Strategic Moves and Developments
• 9.10. Yukon Medical
  • 9.10.1. Company Overview
  • 9.10.2. Key Executives
  • 9.10.3. Company Snapshot
  • 9.10.4. Operating Business Segments
  • 9.10.5. Product Portfolio
  • 9.10.6. Business Performance
  • 9.10.7. Key Strategic Moves and Developments

관련자료